FDA report urges stronger warnings for acetaminophen

05/27/2009 | Bloomberg

An FDA working group released a report urging reduced doses of drugs containing acetaminophen and warnings about liver injury linked to such drugs. The report, which also advises against using acetaminophen in nonprescription combination products such as Tylenol Cold, will be discussed by FDA advisory panels June 29 and 30.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA